Reliability of the Beck Depression Inventory in opiate-dependent patients

@article{Barral2014ReliabilityOT,
  title={Reliability of the Beck Depression Inventory in opiate-dependent patients},
  author={Carmen Barral and Laia Rodr{\'i}guez-Cintas and Nieves Mart{\'i}nez-Luna and Diana Bachiller and Jes{\'u}s P{\'e}rez-Pazos and Joan Alvar{\'o}s and Miguel Casas and Carlos Roncero},
  journal={Journal of Substance Use},
  year={2014},
  volume={21},
  pages={128 - 132}
}
Abstract Background: The prevalence of depressive disorder in opioid-dependent patients in methadone treatment has been found to be between 19 to 74.3%. Beck Depression Inventory (BDI) is commonly used as a screening for depressive symptoms. The objective of this study is assessing BDI in opiate-dependent patients. Methods: A total of 415 patients over 18 years old in a methadone maintenance program that is part of an outpatient drug clinic treated with stable doses of methadone in the last… Expand
Anxiety and Depression in Drug-Dependent Patients with Cluster C Personality Disorders
TLDR
Interventions should focus on aspects like depression and anxiety more than on the substance consumed, being greater alcohol consumption as well as abuse of both stimulants and depressants in Cluster C patients. Expand
Is complicated grief a risk factor for substance use? A comparison of substance-users and normative grievers
Abstract Background: There are no studies to date which have examined complicated grief (CG) symptomatology in substance use disorder (SUD) populations specifically. This study aimed to determine ifExpand
Factor structure and concurrent construct validity of ICG among bereaved substance users.
TLDR
The results of the current study confirm the multidimensionality of CG’s symptomatology construct and the Spanish IDC shows good psychometric properties and it is a useful tool to discriminate adaptive reactions to symptom atology of complicated grief. Expand
Exploring Relationships of Meaning, Co-Occurring Diagnoses, and Attitudes About Substances
Exploring Relationships of Meaning, Co-Occurring Diagnoses, and Attitudes About Substances by Misty Grant MA, Argosy University, 2012 BS, University of Utah, 2010 Dissertation Submitted in PartialExpand
La validación de instrumentos psicométricos: un asunto capital en la salud mental
La creacion, validacion y adaptacion de escalas, entrevistas estructuradas y otros instrumentos psicometricos conforman una parte fundamental de la psiquiatria actual. Los instrumentos deben serExpand
Estructura factorial y validez de constructo concurrente del IDC entre usuarios de drogas en duelo
espanolIntroduccion. Es importante entender las repercusiones del duelo complicado (DC) en el ambito de las adicciones. Hasta la fecha no hay estudios que hayan examinado las propiedadesExpand

References

SHOWING 1-10 OF 35 REFERENCES
The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment.
  • M. Hesse
  • Psychology, Medicine
  • The British journal of clinical psychology
  • 2006
TLDR
The BDI measures a construct that is both stable and of predictive validity in a sample of non-abstinent opiate agonist maintenance patients, although very severe drug use at baseline appeared to reduce the stability of the BDI. Expand
Integrated treatment of comorbid depression and substance use disorders.
TLDR
Depression comorbidity may not have had a negative impact on the course and outcome of addiction treatment because the dual disorder was identified at the initial assessment, and integrated psychiatric care was available. Expand
Depression in methadone maintenance treatment patients: rate and risk factors.
TLDR
The major risk factors for depression were already being in MMT, female gender, any DSM-IV Axis I psychiatric diagnosis, taking any psychotropic medication, abuse or using prescribed BDZ, and methadone dose > 120 mg/day. Expand
Detecting depressive disorders in drug abusers: a comparison of screening instruments.
TLDR
The results showed that the Beck Depression Inventory, a 13-item patient self report was the most sensitive and specific and is recommended for screening drug-dependent populations for depression. Expand
Comparing the BDI-II and the PHQ-9 with outpatient substance abusers.
TLDR
Both self-report measures of depression and substance abusers were correlated with severity levels of alcohol and drug use and advantages and disadvantages of using both measures with substance abusers are discussed. Expand
A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
TLDR
Two of the most commonly used depressive symptomatology measures in a sample of clients in residential substance abuse treatment settings evaluated demonstrated good internal consistency reliability, but the PHQ-9 classifies more individuals as having "mild" depression symptoms relative to the BDI-II, which tends to suggest these individuals have no depression symptoms. Expand
Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users.
TLDR
The factor structure of the BDI-II and its ability to detect clinical depression, defined as the presence of a Major Depressive Disorder (MDD) or substance-induced depression, were examined. Expand
Predictors of the severity of depressive symptoms among intravenous heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
  • Peng-Wei Wang, Hung-Chi Wu, +4 authors C. Yen
  • Medicine
  • Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
  • 2012
TLDR
It is found that sociodemographic and substance-using characteristics at baseline predicted the severity of depressive symptoms among heroin users receiving methadone maintenance treatment (MMT) in Taiwan. Expand
Effects of major depression on remission and relapse of substance dependence.
TLDR
The timing of depressive episodes relative to substance dependence served as an important factor in the remission and relapse of substance dependence and substance use. Expand
Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
TLDR
The findings of this study illustrate the need to consider depression in the treatment of heroin dependence by showing depressed individuals had less exposure to methadone/buprenorphine maintenance and residential rehabilitation for the follow-up period, but spent more time in detoxification. Expand
...
1
2
3
4
...